I’ve been watching this space long enough to know when the numbers deserve a double take. Spot XRP exchange-traded funds have logged nine straight sessions of inflows, pulling in roughly $170 million over eleven trading days. That’s not a blip. That’s a signal.
And the signal gets louder when you look at who’s holding the bags. Second quarter 13F filings dropped this week, and the institutional lineup for XRP ETFs reads like a who’s who of Wall Street alpha. Goldman Sachs, Jane Street, Millennium Management, they’re all in. Not as a joke, not as a small bet. As real positions.
Let me be clear: this isn’t 2021 retail frenzy spilling into a new wrapper. This is the smartest money in finance putting hard dollars behind a token that spent years fighting the SEC. Something shifted.
The $170 Million Question: Who’s Buying and Why
The inflow streak started in late July and hasn’t let up. According to data from CoinShares, spot XRP products saw $22.1 million in net inflows for the week ending August 2 alone. That extended the run to nine consecutive days of positive flows. Total assets under management for XRP ETPs now sit north of $1.1 billion.
For context, that’s roughly 2% of the entire crypto ETP market. Not earth-shattering, but for a token that was deemed a security by the SEC until last July’s court ruling, it’s a remarkable recovery.
What’s driving it? My read is a combination of three things. First, the legal clarity from Judge Torres’s ruling gave institutional compliance officers cover they didn’t have before. Second, the broader crypto ETF wave, Bitcoin and Ethereum products have normalised the asset class for RIAs and pension funds. Third, and this is the one nobody talks about enough, XRP has a functional use case in cross-border payments that most meme coins can’t touch.
The inflows aren’t evenly distributed, either. The bulk is going to products from Grayscale, Bitwise, and 21Shares. Grayscale’s XRP Trust alone has pulled in over $60 million in the past two weeks. That’s a trust, not even an ETF, the fee structure is higher, and investors are still piling in.
Goldman, Jane Street, Millennium: The 13F Reality Check
When the second quarter 13F filings started trickling in, I expected to see some familiar names. What I didn’t expect was the concentration.
Goldman Sachs reported a position worth roughly $15 million in the Grayscale XRP Trust. Jane Street Capital disclosed about $8 million across two XRP products. Millennium Management, the multi-strategy hedge fund with $60 billion in AUM, showed a $12 million allocation.
These aren’t speculative punts from the prop desk. These are institutional allocations filed with the SEC, subject to public scrutiny. The message is clear: XRP has graduated from retail casino to institutional portfolio staple.
Compare this to where we were two years ago. In 2022, the SEC’s lawsuit against Ripple was in full swing. Exchanges delisted XRP. Market makers pulled liquidity. The token traded at $0.30. Today, it’s hovering around $0.60 with a $33 billion market cap, and Goldman Sachs is a holder.
That’s not just a comeback. That’s a complete inversion of the risk narrative.
The irony isn’t lost on me. The same SEC that sued Ripple for selling unregistered securities is now receiving filings from Goldman showing they bought those same securities, sorry, that same non-security, as the court ruled, through a regulated trust structure. The regulatory arbitrage is almost beautiful.
And it’s not just the big three. Other filers include Susquehanna International Group, which disclosed $6.5 million in XRP exposure, and a handful of smaller RIAs. The institutional breadth is widening.
What This Means for the Crypto ETF Landscape
The XRP ETF story is part of a larger narrative that the market is ignoring at its peril. We’ve seen Bitcoin ETFs pull in $17 billion in their first six months. Ethereum ETFs launched to $1 billion in week one. Now XRP is the third crypto asset to get serious institutional buy-in.
But here’s the catch: XRP doesn’t have a spot ETF yet. Not a real one, anyway. The products attracting these inflows are trusts and exchange-traded products listed in Europe and Canada. The US still lacks a spot XRP ETF, though Grayscale and Bitwise have filed applications with the SEC.
The regulatory path is not guaranteed. The SEC could still appeal the Ripple ruling, and the agency’s track record on crypto ETFs is cautious at best. But the market is voting with capital. If the SEC approves a spot XRP ETF, the floodgates could open. We’re talking about potential inflows of $5 to $10 billion in the first year, based on the Bitcoin ETF analog.
For comparison, the market is currently pricing in less than a 30% chance of approval by year-end, according to Polymarket. That feels low to me. The institutional demand is already proven. The legal framework is more settled than it’s ever been. And the SEC has shown it can approve crypto ETFs when the political pressure is sufficient.
If you’re a retail investor watching from the sidelines, the playbook is simple: watch the SEC’s next move on the Grayscale and Bitwise filings. If they get a 19b-4 acknowledgment, expect a rally. If they get a denial, expect a correction. Either way, the institutions have already made their bet.
The Second-Order Effects: Who Wins and Who Loses
Let’s talk about the winners and losers in this new regime.
Winners: Ripple Labs, obviously. A higher XRP price and institutional validation gives them more runway for their On-Demand Liquidity product. Coinbase, which lists XRP and serves as custodian for several of these trusts. And the broader crypto ETF ecosystem, every approval normalises the asset class further.
Losers: The SEC, if they try to block a spot ETF now that institutions are already holding the asset. And the legacy cross-border payment networks like SWIFT, which face a faster, cheaper competitor that just got a Wall Street endorsement.
There’s also a subtler loser: the average retail trader who sold XRP during the SEC lawsuit at a loss. Many of them capitulated at $0.20 or $0.30, convinced the token was dead. They missed the institutional wave. That’s the cruelty of crypto cycles, the smart money buys when the headlines are worst, and sells when the narrative flips.
Speaking of cycles, if you think this market is disconnected from broader economic reality, check out our piece on the market ignoring jobs data. The disconnect between crypto inflows and traditional macro signals is getting harder to ignore.
And if you’re wondering whether regulatory crackdowns can still hit crypto, the NCA freezing $13.6 million of Premier League money in the Sorare probe shows that the compliance risk hasn’t disappeared. It’s just shifted.
Frequently Asked Questions
Frequently Asked Questions
Why are institutions buying XRP now after years of avoiding it?
The July 2023 court ruling that XRP is not a security when sold on exchanges removed the primary legal risk that kept institutions away. Combined with the success of Bitcoin and Ethereum ETFs, compliance officers now have a clear framework to allocate to XRP products. The 13F filings confirm this shift is real, not speculative.
Does Goldman Sachs actually hold XRP tokens, or just derivatives?
Goldman’s 13F filing shows a position in the Grayscale XRP Trust, which holds spot XRP tokens. This is direct exposure to the underlying asset, not a derivative or synthetic product. The trust structure means Goldman doesn’t custody the tokens directly, but the economic exposure is identical to holding XRP.
Will the SEC approve a spot XRP ETF in the US?
It’s possible but not guaranteed. The SEC has acknowledged filings from Grayscale and Bitwise for spot XRP ETFs, but the agency has a 240-day review period. The key factor is whether the SEC appeals the Ripple ruling. If the ruling stands, approval becomes more likely. If the SEC appeals and wins, it could delay or block an ETF. Market odds on Polymarket currently sit below 30% for 2024 approval.
